Incidence and predictors of severe altitude illness symptoms in Mt. Kilimanjaro hikers: a prospective cohort study

Mieke Croughs, Gissela B. Nyakunga, Francis M. Sakita, Kajiru Kilonzo, Blandina T. Mmbaga, Patrick Soentjens

Research output: Contribution to journalA1: Web of Science-article

Abstract

Background Each year several Mt. Kilimanjaro hikers die due to altitude illness (AI) although urgent descent is technically easily possible. The objectives of this study were to determine the incidence and predictors of severe altitude illness (SAI) symptoms and of summit success in Mt. Kilimanjaro hikers, and the measures taken when AI symptoms develop. Methods A prospective observational cohort study in Mt. Kilimanjaro hikers was conducted from December 2019 until March 2020. Participants were asked to complete a questionnaire at the entrance gate and one at the descend gate. A multivariate logistic regression was performed to study the relations between the variables. Results A total of 1237 recreational hikers and 266 porters or guides were included. The incidence of severe symptoms was 8.6% in recreational hikers and 1.5% in porters and guides. One percent (1.1%) of hikers was hospitalized due to SAI. A history of SAI, young age, summit failure and lack of clear advice predicted the development of severe symptoms. Uhuru peak was reached by 87.9% of the hikers. Absence of severe symptoms, acetazolamide prophylaxis, climbing higher in daytime, young age and climbing in more days predicted summit success. The majority climbed further despite the presence of mild or severe symptoms. The only measure taken in case of mild symptoms that was associated with a lower incidence of severe symptoms was not climbing further. Conclusion The incidence of SAI symptoms in Mt. Kilimanjaro hikers was observed to be high. However, how hikers reacted during symptoms was not appropriate. Therefore, travel health counsellors should emphasize even more that hikers do not ascend higher until mild symptoms have resolved and that it is vital to descend immediately when severe symptoms develop. In addition, they can be informed on the measures, which improved summit success.

Original languageEnglish
Article numbertaac044
JournalJournal of Travel Medicine
Number of pages8
ISSN1195-1982
DOIs
Publication statusPublished - 2022

Keywords

  • Travel
  • altitude sickness
  • predictors
  • incidence
  • advice
  • symptoms
  • Mt
  • Kilimanjaro climbers
  • ACUTE MOUNTAIN-SICKNESS
  • RISK-FACTORS
  • PREVENTION
  • TREKKERS
  • TREKKING
  • ACETAZOLAMIDE
  • DETERMINANTS
  • PREVALENCE
  • GUIDELINES
  • TRAVELERS

Cite this